Dendreon Corporation (Nasdaq: DNDN) announced the following PROVENGE® (sipuleucel-T) data presentations taking place at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida and the Society of Urologic Oncology (SUO) Annual Meeting in Bethesda, Maryland. The following data presentations will take place at the ASH Annual Meeting on Saturday, December 4, 2010, at 5:30 p.m...
More...
More...